FDA advisers back Novavax COVID-19 shots as new option

Please subscribe to IBJ to decode this article.

fn siocbdoihA tard esvo. pic enACtttae Ttorosshhaeo a mnnriasgmgtarh dmnotanaIeteowae ea nyoVue ht’ os mhcleaiDrvis annd ita-iuet, yoi19got gdty oas otocdthdt nsead euOan dtr vFt iDckra egicnl

sn di.cotsaetnne.xxethcmiaoav y eyzNins oe tehae h uan lhiohi ,v iaet ndoytt e.eutFr nmcrtdlwaeb'' eoScioacN,cvaad At tD i Umhhhdesoev r etc oeolttohtaprntcvoremamaptn oaewg

oly nea nal y tu.aa s p.sehflNra e ae n.y ehd- x.mdrsasdAorhfocanvra,aau desoineEaneocdeoM rsrlszeroCr te,i dcdefoph iaup at du rltuatutsSkvrynn Ut oiabaesaoc aBr

ntA i—tla'r ccerhas visisi gm c n crevvaeteDofcrolrae. dnln ereSoldea—isuiiarehtis.o ote.p eFhttnerhes khttio eM dcaconeet lsm a aP Dn e ehocvohi hewscsuntyeae U r .sr i

tra hiepsghme tiherles lmptusal swdwertot ".mtenepmtt ”l t ilgedapsmbctrueeitkc o edkoaoS-isa tdhss elcpoayane,a aaeMof lrt"ynae evgitcado.rnve t tp iosy wnee agte oitst eepn tcshd d nn reiooher c n“ oci totleua ihf ooAlceveiv oWefh Ueiwpa b

avafsde —eal woyvaecrs t lwFhgl tl'hirdy .ion aosta in vsvt aast oasyowmu sei,i aphrcichetoO hrnDisaoe du’i eoohiTnUslreuacovoco co r anor t. rSrch ge rcbt ,a dien inr oaeNoe ia hoee e ltute ahehac e e7arunaotnmhixut sgeetnfa ws.nvh hsetndlsfoydtb b’ p uooloebet ee es.t,ls oy eoissw stdNllehe titefc2eioxagshathot o’rv vca a iaam. e ro l Eanallb dzsymuwniedycdp mclelott.aao Aluo fnsw alIvvehsi

io t gv at y2o tdao :vxwibnsntaisvssi oh iftrooenad oqee?nvress Nhyoeu y tyscs,0ianeot- np tys i asyoF.teuleTavrh te dh tDTahto nbfcferavbDiekmdoA u oeain e eh dt’a etoewhwp1

lta.n rlmoMdt d sfses- ocLsei t1useoon aft pn g ceeseer 9os e9 eee rvsefanvsfninai tos neh tttctveda,usndel ovnnemceiafw inr:aa gih ctUaONo rd eegu OinyihigTucaeefpenmpdet n x iipeiiti s iacft rv.nx iioSnrrtoeevn B iutvuDenn ttooaihotnobseer,eic.C aeddoi mm.rarrmca lv oaamoaw — lglw noori sadwde IrbdteVeo%trca emiach c t0uura

do sueomDhhki otadacvcapdvye fre edimucaeeunng repel iatehirtt v sos. obie t tily lFvmfdoo vta arapttfcN d lnhafauiitnso ahe vs eyn -ca.rhbx ksdeD—dbaislctduiagsr ii totta

uo evkbenari.gsyp we ye caTlsha alagy e et n h nssanpAmbt npdrti start”vio t“ nfdssreddvaoDehiroootf aianiF ec roranh ai aeee mr,a

se,,n ide-Aaoer spiuftlcecaeciolliihunm hdyhec mtce Aolpw snrfecle inioat ei yrso eic 0 siidml0cttr ns n4brom gegoat :cir0cwra htfhtejigod tthi cl .oht snssnl n,shhpxe eopnninulee s e tgaaai0pndyisepvuaeaiewtai ieldhkxnelgs oe,ohwridDie a dovofdseaFndpranionnosaeh eetm

ooetfeansrpi a s Mhrcru eni.tfo rilhtcenren idntintat ows esdet raaaiiaonfPsreuii r otf hlhm Vm eiiy er cbkrsslgmhctoetd feea ttos eayn acdr n rlzotha k

no0iseooheCuma aahnehiatc cdvna 1eTt sndyhcrnhV4forlaae rce in-a ' . rol os ta a ere.fa I i 9instf7 ocin n e msanar trme Oeot,sc taeN vuouri eeh soenusoir rswoh p4cirsteto uog t xwrcvasnsteecfafse ,isitshs,h olilosttpttti nmpalro.ssDhsy leaat0em pa0ateoaf

cTlcieianiethmtke md ypndoabproea a-hssc etttn psvanra sne nrtepdfgsauu n t gseshd h fhteoanTmdu aoom oeh nf i,cnu ibcoosk smaieum st f.n anurtoek svoi o tom caetrirsthn dm eeit ssgclb ntaieeeasusv p jt erir es a dsnooaNu r.e mdeteuprsr t tttsi r,hraeo iini,mu opar trieo skloenpenahi eo auvp t tdah looelgstAievcgeh oa m’ai esxfo anesvarhe ccrtaocs etkhmgarStoinataoa

sn.ehlni t ncs eprsave ius ,adeofvtPdtgbdrseeehito erci es ta tars er as iaepnoshh y ieveoennB

ereons .nlas&roeeuss uT.n duuecriere dinJsi cgveyru nnri adc syrrtiknodii et tpnecnM’ isotahnhyeswnld aJre;pterpact oovrfwv ef bs zf il si atuctruei nstfh s e e oednttiscnsm euli amctS sp.tcalvdthhdieo ncsvPoot Thepoif.cotdetso i teiedtrUvirhhoe oedyee

cccvt hsme xehe o nlbeelvcst hs sndetmt lenomotocxer utSst, tdnuttlruhhsvbis ntoio esbmiypas a vfsic trg coes bavlatgat ubNarmaefgl d,lrldn r claherd eeiltcnh uvbrieve e. re adrd, nM onle i,Sihebosnuyno c c isdcha unercp. s aovao ih sIsmp’c itfw e.fro at tvoeNadaiapar ’mahkIeatnt,Uaoeeeaauoo pssitpuseemh